Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChongqing Medical University
About this trial
This is a prospective, single-center, single-arm study evaluating endoscopic ultrasound-guided ethanol ablation for left-sided aldosterone-producing adenoma. Eligible participants will receive the ablation procedure and be followed for safety, imaging response, biochemical remission, and clinical remission. The study is expected to enroll 30 participants.
Eligibility criteria
Qualifiers
Diagnosis of left-sided aldosterone-producing adrenal adenoma.
Unwillingness to undergo adrenalectomy or presence of contraindications to surgery.
Ability and willingness to provide written informed consent.
Disqualifiers
History of alcohol allergy.
Inability to discontinue beta-blockers.
Inability to discontinue anticoagulants, antiplatelet agents, or glucocorticoids.
Platelet count <50 × 10^9/L or uncorrectable coagulation dysfunction.
Trial design
Treatments tested in this trial
- Endoscopic Ultrasound-Guided Ethanol Ablation
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Chongqing Medical University
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Sponsor institution
Source ClinicalTrials.gov